Sep 5 2009
Nanomedicine - the science and technology of diagnosing, treating and preventing disease to improve human health using nanotechnology - has the potential to revolutionize healthcare. Current and future products range from miniaturized "smart pills" that precision-target certain cancers to nanosensors that are capable of navigating through the body for early detection of disorders. These approaches have the ability to reduce toxicity for the patient, thereby improving efficacy and patient compliance. The newly formed American Society for Nanomedicine (ASNM) is holding its inaugural conference on October 22-25, 2009 in the Washington D.C. area, where some of the biggest stakeholders in this emerging technology operate and practice.
This major interdisciplinary international conference is designed for physicians, scientists, policy-makers, engineers, lawyers and educators from government, academia and industry. The conference venue is the Bolger Center in Potomac, Maryland, USA (http://www.dolce-bolger-center-hotel.com/).
This four-day conference will highlight numerous cutting-edge presentations broken up into various sessions focusing on innovations in nanomedicine and applications of nanotechnology to the pharmaceutical, device and biotechnology industries. It will feature more than forty speakers, who are among the top researchers and leaders in various facets of nanomedicine throughout the world. The areas of emphasis are clinical applications of nanotechnology enabling successful vaccine development, effective cancer therapy and novel drug delivery approaches. In addition, issues such as ethics, safety and toxicity, patent law, intellectual property and commercialization will be addressed. Poster sessions, an award ceremony and numerous networking opportunities are included.
Source: http://www.amsocnanomed.org
Remote interpreting raises concerns about communication quality in healthcare